This study is in progress, not accepting new patients
Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California
- Dates
- study startedcompletion around
- Principal Investigator
- by Andrew Sharabi, MD, PhD
Description
Summary
Official Title
Details
Keywords
Eligibility
Location
Lead Scientist at UCSD
- Andrew Sharabi, MD, PhD
Dr. Andrew Sharabi is a physician scientist and board-certified radiation oncologist at UC San Diego Moores Cancer Center. He sees patients at the La Jolla Moores Cancer Center and his specialties include Prostate (Genitourinary) and Head and Neck Cancers.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Diego
- ID
- NCT02843165
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 146 study participants
- Last Updated